28
Views
79
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Erythroid Differentiation Sensitizes K562 Leukemia Cells to TRAIL-Induced Apoptosis by Downregulation of c-FLIP

, , , , &
Pages 1278-1291 | Received 16 Jul 2002, Accepted 18 Nov 2002, Published online: 27 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mohammed Hafiz Uddin, Julio M. Pimentel, Madhumita Chatterjee, Joshu E. Allen, Zhengping Zhuang & Gen Sheng Wu. (2020) Targeting PP2A inhibits the growth of triple-negative breast cancer cells. Cell Cycle 19:5, pages 592-600.
Read now
Olivier Micheau. (2003) Cellular FLICE-inhibitory protein: an attractive therapeutic target?. Expert Opinion on Therapeutic Targets 7:4, pages 559-573.
Read now

Articles from other publishers (77)

Ya. V. Lomovskaya, M. I. Kobyakova, A. S. Senotov, I. S. Fadeeva, A. I. Lomovsky, K. S. Krasnov, D. Yu. Shtatnova, V. S. Akatov & R. S. Fadeev. (2023) Myeloid Differentiation Increases Resistance of Leukemic Cells to TRAIL-Induced Death by Reducing the Expression of DR4 and DR5 Receptors. Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology 17:1, pages 43-57.
Crossref
Greta Leonaviciene & Linas Mazutis. (2023) RNA cytometry of single-cells using semi-permeable microcapsules. Nucleic Acids Research 51:1, pages e2-e2.
Crossref
Victoria Simões Bernardo, Flaviene Felix Torres, Carla Peres de Paula, João Pedro Maia de Oliveira da Silva, Eduardo Alves de Almeida, Anderson Ferreira da Cunha & Danilo Grünig Humberto da Silva. (2022) Potential Cytoprotective and Regulatory Effects of Ergothioneine on Gene Expression of Proteins Involved in Erythroid Adaptation Mechanisms and Redox Pathways in K562 Cells. Genes 13:12, pages 2368.
Crossref
Asuka Watanabe, Misa Togi, Terutsugu Koya, Makoto Taniguchi, Takuya Sakamoto, Kuniyoshi Iwabuchi, Tomohisa KatoJr.Jr. & Shigetaka Shimodaira. (2021) Identification of CD56 dim subpopulation marked with high expression of GZMB/PRF1/PI‐9 in CD56 + interferon‐α‐induced dendritic cells . Genes to Cells 26:5, pages 313-327.
Crossref
Catherine J. Andersen, Lydia Dupree, Kristina Murray, Nicholas Ragonesi, Kaley McMullen, Layra Cintrón‐Rivera & Adam Doerr. (2020) Low‐Density Lipoproteins, High‐Density Lipoproteins (HDL), and HDL‐Associated Proteins Differentially Modulate Chronic Myelogenous Leukemia Cell Viability. Lipids 55:6, pages 615-626.
Crossref
Erasto Desales‐Salazar, Ameer Khusro, Moisés Cipriano‐Salazar, Alberto Barbabosa‐Pliego & Raymundo Rene Rivas‐Caceres. (2020) Scorpion venoms and associated toxins as anticancer agents: update on their application and mechanism of action. Journal of Applied Toxicology 40:10, pages 1310-1324.
Crossref
Samreen Sadaf, Deepika Awasthi, Abhishek Kumar Singh, Sheela Nagarkoti, Sachin Kumar, Manoj Kumar Barthwal & Madhu Dikshit. (2020) Pyroptotic and apoptotic cell death in iNOS and nNOS overexpressing K562 cells: A mechanistic insight. Biochemical Pharmacology 176, pages 113779.
Crossref
Jianping Zhu, Jia Hao Yeo, Amy A Bowyer, Nicholas Proschogo & Elizabeth J New. (2020) Studies of the labile lead pool using a rhodamine-based fluorescent probe. Metallomics 12:5, pages 644-648.
Crossref
Samreen Sadaf, Abhishek Kumar Singh, Deepika Awasthi, Sheela Nagarkoti, Ashok Kumar Agrahari, Rajeshwar Nath Srivastava, Kumaravelu Jagavelu, Sachin Kumar, Manoj Kumar Barthwal & Madhu Dikshit. (2019) Augmentation of iNOS expression in myeloid progenitor cells expedites neutrophil differentiation. Journal of Leukocyte Biology 106:2, pages 397-412.
Crossref
Amandine Pradier, Maria Papaserafeim, Ning Li, Anke Rietveld, Charlotte Kaestel, Lyssia Gruaz, Cédric Vonarburg, Rolf Spirig, Gisella L. Puga Yung & Jörg D. Seebach. (2019) Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions in vitro. Frontiers in Immunology 10.
Crossref
Xun Yuan, Dhonghyo Kho, Jing Xu, Ambikai Gajan, Kongming Wu & Gen Sheng Wu. (2017) ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells. Oncotarget 8:13, pages 21626-21638.
Crossref
Fanni Dittmar, Sabine Wolter & Roland Seifert. (2016) Regulation of apoptosis by cyclic nucleotides in human erythroleukemia (HEL) cells and human myelogenous leukemia (K-562) cells. Biochemical Pharmacology 112, pages 13-23.
Crossref
Alexandra C. Vrazo, Adrianne E. Hontz, Sarah K. FigueiraBraeden L. Butler, Julie M. FerrellBrock F. Binkowski, Jinzhu LiKimberly A. Risma. (2015) Live cell evaluation of granzyme delivery and death receptor signaling in tumor cells targeted by human natural killer cells. Blood 126:8, pages e1-e10.
Crossref
Yu-Wen HuangWei-Hwa Lee, Yu-Hui Tsai & Huei-Mei Huang. (2014) Activin A induction of erythroid differentiation sensitizes K562 chronic myeloid leukemia cells to a subtoxic concentration of imatinib. American Journal of Physiology-Cell Physiology 306:1, pages C37-C44.
Crossref
Jian Ma, Youtian Hu, Mingxiong Guo, Zan Huang, Wenxin Li & Yingliang Wu. (2013) hERG Potassium Channel Blockage by Scorpion Toxin BmKKx2 Enhances Erythroid Differentiation of Human Leukemia Cells K562. PLoS ONE 8:12, pages e84903.
Crossref
Christopher Pelham, Tamara Jimenez, Marianna Rodova, Angela Rudolph, Elizabeth Chipps & M. Rafiq Islam. (2013) Regulation of HFE expression by poly(ADP-ribose) polymerase-1 (PARP1) through an inverted repeat DNA sequence in the distal promoter. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1829:12, pages 1257-1265.
Crossref
Jing Xu, Zhengfan Xu, Jun-Ying Zhou, Zhengping Zhuang, Enhua Wang, Julie Boerner & Gen Sheng Wu. (2013) Regulation of the Src-PP2A Interaction in Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis. Journal of Biological Chemistry 288:46, pages 33263-33271.
Crossref
Dan Xie, Alan P. Boyle, Linfeng Wu, Jie Zhai, Trupti Kawli & Michael Snyder. (2013) Dynamic trans-Acting Factor Colocalization in Human Cells. Cell 155:3, pages 713-724.
Crossref
Sibaji SarkarDouglas V. Faller. (2013) Telomere-Homologous G-Rich Oligonucleotides Sensitize Human Ovarian Cancer Cells to TRAIL-Induced Growth Inhibition and Apoptosis. Nucleic Acid Therapeutics 23:3, pages 167-174.
Crossref
Yuan Shi, Gregory Mellier, Sinong Huang, Jacob White, Shazib Pervaiz & Lisa Tucker-Kellogg. (2013) Computational modelling of LY303511 and TRAIL-induced apoptosis suggests dynamic regulation of cFLIP. Bioinformatics 29:3, pages 347-354.
Crossref
Hongqin Zhuang, Weiwei Jiang, Xiangyu Zhang, Fan Qiu, Ziyi Gan, Wei Cheng, Jing Zhang, Shengwen Guan, Bo Tang, Qilai Huang, Xinhua Wu, Xiaofeng Huang, Wenhui Jiang, Qingang Hu, Min Lu & Zi-Chun Hua. (2012) Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions. Journal of Molecular Medicine 91:2, pages 219-235.
Crossref
Zhenzhen Zhang, Tingmei Ye, Xueting Cai, Jie Yang, Wuguang Lu, Chunping Hu, Zhigang Wang, Xiaoning Wang & Peng Cao. (2013) 5,7-Dihydroxyflavone Enhances the Apoptosis-Inducing Potential of TRAIL in Human Tumor Cells via Regulation of Apoptosis-Related Proteins. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-13.
Crossref
Hima Bansal, Theresea Seifert, Carlos Bachier, Manjeet Rao, Gail Tomlinson, Swaminathan Padmanabhan Iyer & Sanjay Bansal. (2012) The Transcription Factor Wilms Tumor 1 Confers Resistance in Myeloid Leukemia Cells against the Proapoptotic Therapeutic Agent TRAIL (Tumor Necrosis Factor α-related Apoptosis-inducing Ligand) by Regulating the Antiapoptotic Protein Bcl-xL. Journal of Biological Chemistry 287:39, pages 32875-32880.
Crossref
Hak-Bong Kim, Mi-Ju Kim, Su-Hoon Lee, Jae-Won Lee, Jae-Ho Bae, Dong-Wan Kim, Trong Tuan Dao, Won Keun Oh, Chi-Dug Kang & Sun-Hee Kim. (2012) Amurensin G, a novel SIRT1 inhibitor, sensitizes TRAIL-resistant human leukemic K562 cells to TRAIL-induced apoptosis. Biochemical Pharmacology 84:3, pages 402-410.
Crossref
Rosa Martín-Pérez, Maho Niwa & Abelardo López-Rivas. (2011) ER stress sensitizes cells to TRAIL through down-regulation of FLIP and Mcl-1 and PERK-dependent up-regulation of TRAIL-R2. Apoptosis 17:4, pages 349-363.
Crossref
Harrie A. Verhoeven & Leo J. L. D. van Griensven. (2012) Flow cytometric evaluation of the effects of 3-bromopyruvate (3BP) and dichloracetate (DCA) on THP-1 cells: a multiparameter analysis. Journal of Bioenergetics and Biomembranes 44:1, pages 91-99.
Crossref
Yvonne J. Yamanaka, Christoph T. Berger, Magdalena Sips, Patrick C. Cheney, Galit Alter & J. Christopher Love. (2012) Single-cell analysis of the dynamics and functional outcomes of interactions between human natural killer cells and target cells. Integrative Biology 4:10, pages 1175.
Crossref
Hongyun Tang, Yong Qin, Jianyong Li & Xingguo Gong. (2011) The scavenging of superoxide radicals promotes apoptosis induced by a novel cell-permeable fusion protein, sTRAIL:FeSOD, in tumor necrosis factor-related apoptosis-inducing ligand-resistant leukemia cells. BMC Biology 9:1.
Crossref
Xing Du, Laiman Xiang, Crystal Mackall & Ira Pastan. (2011) Killing of Resistant Cancer Cells with Low Bak by a Combination of an Antimesothelin Immunotoxin and a TRAIL Receptor 2 Agonist Antibody. Clinical Cancer Research 17:18, pages 5926-5934.
Crossref
Regina Golan-Gerstl, Michal Cohen, Asaf Shilo, Sung-Suk Suh, Arianna Bakàcs, Luigi Coppola & Rotem Karni. (2011) Splicing Factor hnRNP A2/B1 Regulates Tumor Suppressor Gene Splicing and Is an Oncogenic Driver in Glioblastoma. Cancer Research 71:13, pages 4464-4472.
Crossref
Xiaochun Zhang, Takeshi Inukai, Koshi Akahane, Kinuko Hirose, Itaru Kuroda, Hiroko Honna, Kumiko Goi, Keiko Kagami, Tetsuzo Tauchi, Hideo Yagita & Kanji Sugita. (2011) Endoplasmic reticulum stress inducers, but not imatinib, sensitize Philadelphia chromosome-positive leukemia cells to TRAIL-mediated apoptosis. Leukemia Research 35:7, pages 940-949.
Crossref
Han-Sung Lee, Kwang-Ho Cho, Tae-Kyung Kim, Choon-Hwan Kim, Soo-Jung Ahn, Eun-Hui Lee, Kyoo-Seok Ahn & Yun-Jae Jung. (2011) Cho-kyung-jong-ok-tang, a traditional Korean herbal formula induces type 2 shift in murine natural killer cell cytokine production. Journal of Ethnopharmacology 134:2, pages 281-287.
Crossref
Koshi Akahane, Takeshi Inukai, Xiaochun Zhang, Kinuko Hirose, Itaru Kuroda, Kumiko Goi, Hiroko Honna, Keiko Kagami, Shinpei Nakazawa, Kazushi Endo, Takeo Kubota, Hideo Yagita, Toshiko Koyama-Okazaki & Kanji Sugita. (2010) Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor−related apoptosis-inducing ligand-mediated apoptosis. Experimental Hematology 38:10, pages 885-895.
Crossref
Moo-Seung Lee, Rama P. Cherla, Erin K. Lentz, Dinorah Leyva-Illades & Vernon L. Tesh. (2010) Signaling through C/EBP Homologous Protein and Death Receptor 5 and Calpain Activation Differentially Regulate THP-1 Cell Maturation-Dependent Apoptosis Induced by Shiga Toxin Type 1. Infection and Immunity 78:8, pages 3378-3391.
Crossref
Daniela Vittori, Daiana Vota, Mariana Callero, María E Chamorro & Alcira Nesse. (2010) c-FLIP is involved in erythropoietin-mediated protection of erythroid-differentiated cells from TNF-α-induced apoptosis. Cell Biology International 34:6, pages 621-630.
Crossref
Kerstin A. Stegmann, Niklas K. Björkström, Heike Veber, Sandra Ciesek, Peggy Riese, Johannes Wiegand, Johannes Hadem, Pothakamuri V. Suneetha, Jerzy Jaroszewicz, Chun Wang, Verena Schlaphoff, Paraskevi Fytili, Markus Cornberg, Michael P. Manns, Robert Geffers, Thomas Pietschmann, Carlos A. Guzmán, Hans–Gustaf Ljunggren & Heiner Wedemeyer. (2010) Interferon-α–Induced TRAIL on Natural Killer Cells Is Associated With Control of Hepatitis C Virus Infection. Gastroenterology 138:5, pages 1885-1897.e10.
Crossref
T Sánchez-Pérez, G Ortiz-Ferrón & A López-Rivas. (2009) Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents. Cell Death & Differentiation 17:5, pages 883-894.
Crossref
Jihed Chehimi, Emmanouil Papasavvas, Costin Tomescu, Bethsebah Gekonge, Shaheed Abdulhaqq, Andrea Raymond, Aidan Hancock, Kavita Vinekar, Craig Carty, Griffin Reynolds, Maxwell Pistilli, Karam Mounzer, Jay Kostman & Luis J. Montaner. (2010) Inability of Plasmacytoid Dendritic Cells To Directly Lyse HIV-Infected Autologous CD4 + T Cells despite Induction of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand . Journal of Virology 84:6, pages 2762-2773.
Crossref
Marc Schumacher, Claudia Cerella, Serge Eifes, Sébastien Chateauvieux, Franck Morceau, Marcel Jaspars, Mario Dicato & Marc Diederich. (2010) Heteronemin, a spongean sesterterpene, inhibits TNFα-induced NF-κB activation through proteasome inhibition and induces apoptotic cell death. Biochemical Pharmacology 79:4, pages 610-622.
Crossref
Josep Maria Lluis, Ulrich Nachbur, Wendy Diane Cook, Ian Edward Gentle, Donia Moujalled, Maryline Moulin, Wendy Wei-Lynn Wong, Nufail Khan, Diep Chau, Bernard Andrew Callus, James Edward Vince, John Silke & David Lawrence Vaux. (2010) TAK1 Is Required for Survival of Mouse Fibroblasts Treated with TRAIL, and Does So by NF-κB Dependent Induction of cFLIPL. PLoS ONE 5:1, pages e8620.
Crossref
Gen Sheng Wu. (2009) TRAIL as a target in anti-cancer therapy. Cancer Letters 285:1, pages 1-5.
Crossref
A Kaunisto, V Kochin, T Asaoka, A Mikhailov, M Poukkula, A Meinander & J E Eriksson. (2009) PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability. Cell Death & Differentiation 16:9, pages 1215-1226.
Crossref
Mi-Ju Kim, Hak-Bong Kim, Jae-Ho Bae, Jae-Won Lee, Soo-Jung Park, Dong-Wan Kim, Sang-Ick Park, Chi-Dug Kang & Sun-Hee Kim. (2009) Sensitization of human K562 leukemic cells to TRAIL-induced apoptosis by inhibiting the DNA-PKcs/Akt-mediated cell survival pathway. Biochemical Pharmacology 78:6, pages 573-582.
Crossref
. (2009) Quercetin Sensitizes Human Leukemic Cells to TRAIL-induced Apoptosis: Involvement of DNA-PK/Akt Signal Transduction Pathway. Journal of Life Science 19:8, pages 1023-1032.
Crossref
Marjo Tampio, Piia Markkanen, Katja A. Puttonen, Eveliina Hagelberg, Hannu Heikkinen, Kati Huhtinen, Jarkko Loikkanen, Maija-Riitta Hirvonen & Kirsi H. Vähäkangas. (2009) Induction of PUMA-α and down-regulation of PUMA-β expression is associated with benzo(a)pyrene-induced apoptosis in MCF-7 cells. Toxicology Letters 188:3, pages 214-222.
Crossref
Soo-Jung Park, Mi-Ju Kim, Hak-Bong Kim, Chi-Dug Kang & Sun-Hee Kim. (2009) Sensitization of imatinib-resistant CML cells to TRAIL-induced apoptosis is mediated through down-regulation of Bcr-Abl as well as c-FLIP. Biochemical Journal 420:1, pages 73-81.
Crossref
Claudia Jursik, Michaela Prchal, Regina Grillari-Voglauer, Karel Drbal, Elke Fuertbauer, Herbert Jungfer, Winfried H. Albert, Eva Steinhuber, Thomas Hemetsberger, Johannes Grillari, Hannes Stockinger & Hermann Katinger. (2009) Large-Scale Production and Characterization of Novel CD4+ Cytotoxic T Cells with Broad Tumor Specificity for Immunotherapy. Molecular Cancer Research 7:3, pages 339-353.
Crossref
Sudeshna Seal, David M. Hockenbery, Emily Y. Spaulding, Hans-Peter Kiem, Nissa Abbassi & H. Joachim Deeg. (2008) Differential responses of FLIPLong and FLIPShort-overexpressing human myeloid leukemia cells to TNF-α and TRAIL-initiated apoptotic signals. Experimental Hematology 36:12, pages 1660-1672.
Crossref
Xia Wang, Wenshu Chen, Weihua Zeng, Lang Bai, Yohannes Tesfaigzi, Steven A. Belinsky & Yong Lin. (2008) Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells. Molecular Cancer Therapeutics 7:5, pages 1156-1163.
Crossref
Magda Foresti & Bice Avallone. (2008) Only complete rejoining of DNA strand breaks after UVC allows K562 cell proliferation and DMSO induction of erythropoiesis. Journal of Photochemistry and Photobiology B: Biology 90:1, pages 8-16.
Crossref
Ugo Testa. 2008. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology 1 66 .
Arabinda Das, Naren L. Banik & Swapan K. Ray. (2007) Differentiation Decreased Telomerase Activity in Rat Glioblastoma C6 Cells and Increased Sensitivity to IFN-γ and Taxol for Apoptosis. Neurochemical Research 32:12, pages 2167-2183.
Crossref
Georgina P. Colo, Roberto R. Rosato, Steven Grant & Mónica A. Costas. (2007) RAC3 down-regulation sensitizes human chronic myeloid leukemia cells to TRAIL-induced apoptosis. FEBS Letters 581:26, pages 5075-5081.
Crossref
Viqar Syed, Kasturi Mukherjee, Sonia Godoy-Tundidor & Shuk-Mei Ho. (2007) Progesterone induces Apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression. Journal of Cellular Biochemistry 102:2, pages 442-452.
Crossref
Paula de Melo Campos, Fabíola Traina, Adriana da Silva Santos Duarte, Irene Lorand-Metze, Fernando F. Costa & Sara T.O. Saad. (2007) Reduced expression of FLIPSHORT in bone marrow of low risk myelodysplastic syndrome. Leukemia Research 31:6, pages 853-857.
Crossref
Felipe Andrade, Edward Fellows, Dieter E Jenne, Antony Rosen & C S H Young. (2007) Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition. The EMBO Journal 26:8, pages 2148-2157.
Crossref
Loris Zamai, Cristina Ponti, Prisco Mirandola, Giuliana Gobbi, Stefano Papa, Laura Galeotti, Lucio Cocco & Marco Vitale. (2007) NK Cells and Cancer. The Journal of Immunology 178:7, pages 4011-4016.
Crossref
Annika Meinander, Thomas S. Söderström, Aura Kaunisto, Minna Poukkula, Lea Sistonen & John E. Eriksson. (2007) Fever-Like Hyperthermia Controls T Lymphocyte Persistence by Inducing Degradation of Cellular FLIPshort. The Journal of Immunology 178:6, pages 3944-3953.
Crossref
Gaël Roué, Patricia Pérez-Galán, Mónica López-Guerra, Neus Villamor, Elias Campo & Dolors Colomer. (2007) Selective Inhibition of IκB Kinase Sensitizes Mantle Cell Lymphoma B Cells to TRAIL by Decreasing Cellular FLIP Level. The Journal of Immunology 178:3, pages 1923-1930.
Crossref
Juan Shi, Yanxin Liu, Yong Zheng, Yabin Guo, Jinchun Zhang, Pik-to Cheung, Ruian Xu & Dexian Zheng. (2006) Therapeutic Expression of an Anti-Death Receptor 5 Single-Chain Fixed-Variable Region Prevents Tumor Growth in Mice. Cancer Research 66:24, pages 11946-11953.
Crossref
Carmen Palacios, Rosario Yerbes & Abelardo López-Rivas. (2006) Flavopiridol Induces Cellular FLICE-Inhibitory Protein Degradation by the Proteasome and Promotes TRAIL–Induced Early Signaling and Apoptosis in Breast Tumor Cells. Cancer Research 66:17, pages 8858-8869.
Crossref
Robert C. Briggs, Keith E. Shults, Leanne A. Flye, Sara A. McClintock-Treep, Madan H. Jagasia, Stacey A. Goodman, Fouad I. Boulos, James W. Jacobberger, Greg T. Stelzer & David R. Head. (2006) Dysregulated Human Myeloid Nuclear Differentiation Antigen Expression in Myelodysplastic Syndromes: Evidence for a Role in Apoptosis. Cancer Research 66:9, pages 4645-4651.
Crossref
Ying-Xia Zhang, Yuan-Yuan Wang, Wen-Hui Lee, Yong-Tang Zheng & Yun Zhang. (2006) Apoptotic activity of frog Bombina maxima skin albumin. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 143:2, pages 153-159.
Crossref
Zhanxiang Wang, Janardhan Sampath, Seiji Fukuda & Louis M. Pelus. (2005) Disruption of the Inhibitor of Apoptosis Protein Survivin Sensitizes Bcr-abl–Positive Cells to STI571-Induced Apoptosis. Cancer Research 65:18, pages 8224-8232.
Crossref
Shen GaoPeng LeeHua WangWilliam Gerald, Michael AdlerLiying Zhang, Yun-Fang WangZhengxin Wang. (2005) The Androgen Receptor Directly Targets the Cellular Fas/FasL-Associated Death Domain Protein-Like Inhibitory Protein Gene to Promote the Androgen-Independent Growth of Prostate Cancer Cells. Molecular Endocrinology 19:7, pages 1792-1802.
Crossref
Minna Poukkula, Aura Kaunisto, Ville Hietakangas, Konstantin Denessiouk, Tuire Katajamäki, Mark S. Johnson, Lea Sistonen & John E. Eriksson. (2005) Rapid Turnover of c-FLIPshort Is Determined by Its Unique C-terminal Tail. Journal of Biological Chemistry 280:29, pages 27345-27355.
Crossref
Mehdi ShakibaeiGundula Schulze-TanzilYasunari TakadaBharat B. Aggarwal. (2005) Redox Regulation of Apoptosis by Members of the TNF Superfamily. Antioxidants & Redox Signaling 7:3-4, pages 482-496.
Crossref
Stefanie E.F. Tran, Annika Meinander & John E. Eriksson. (2004) Instant decisions: transcription-independent control of death-receptor-mediated apoptosis. Trends in Biochemical Sciences 29:11, pages 601-608.
Crossref
Xiaoping Zhang, Tai-Guang Jin, Hongmei Yang, William C. DeWolf, Roya Khosravi-Far & Aria F. Olumi. (2004) Persistent c-FLIP(L) Expression Is Necessary and Sufficient to Maintain Resistance to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand–Mediated Apoptosis in Prostate Cancer. Cancer Research 64:19, pages 7086-7091.
Crossref
Irene Kazhdan & Robert A Marciniak. (2004) Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Cancer Gene Therapy 11:10, pages 691-698.
Crossref
U Testa. (2004) Apoptotic mechanisms in the control of erythropoiesis. Leukemia 18:7, pages 1176-1199.
Crossref
Bharat B Aggarwal, Uddalak Bhardwaj & Yasunari Takada. 2004. TRAIL (TNF-Related Apoptosis-Inducing Ligand). TRAIL (TNF-Related Apoptosis-Inducing Ligand) 453 483 .
Christine J Hawkins. 2004. TRAIL (TNF-Related Apoptosis-Inducing Ligand). TRAIL (TNF-Related Apoptosis-Inducing Ligand) 427 452 .
Janina Ratajczak, Magdalena Kucia, Ryan Reca, Jin Zhang, Bogdan Machalinski & Mariusz Z. Ratajczak. (2003) Quiescent CD34 + early erythroid progenitors are resistant to several erythropoietic ‘inhibitory’ cytokines; role of FLIP . British Journal of Haematology 123:1, pages 160-169.
Crossref
A M Martelli, P L Tazzari, G Tabellini, R Bortul, A M Billi, L Manzoli, A Ruggeri, R Conte & L Cocco. (2003) A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Leukemia 17:9, pages 1794-1805.
Crossref
Thomas R Johnson, Kimberley Stone, Malti Nikrad, Tammie Yeh, Wei-Xing Zong, Craig B Thompson, Alexandre Nesterov & Andrew S Kraft. (2003) The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells. Oncogene 22:32, pages 4953-4963.
Crossref
Li-Hong Xu. (2003) Synergistic antitumor effect of TRAIL and doxorubicin on colon cancer cell line SW480. World Journal of Gastroenterology 9:6, pages 1241.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.